To the best of our knowledge, this is the first article investigating the DLL3 immunohistochemical expression and its prognostic role in a consecutive series of limited-stage lung NETs treated with surgery and including all four histological types (TCs, ACs, LCNECs, and SCLCs). This evidence concerns the gene DLL3 and lung neuroendocrine neoplasm.